Review



a311  (Vazyme Biotech Co)


Bioz Verified Symbol Vazyme Biotech Co is a verified supplier
Bioz Manufacturer Symbol Vazyme Biotech Co manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Vazyme Biotech Co a311
    A311, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1860 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a311/product/Vazyme Biotech Co
    Average 99 stars, based on 1860 article reviews
    a311 - by Bioz Stars, 2026-02
    99/100 stars

    Images



    Similar Products

    99
    Vazyme Biotech Co a311
    A311, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/a311/product/Vazyme Biotech Co
    Average 99 stars, based on 1 article reviews
    a311 - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress cell counting kit 8 cck 8 solution
    Cell Counting Kit 8 Cck 8 Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell counting kit 8 cck 8 solution/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    cell counting kit 8 cck 8 solution - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    TargetMol cck 8
    Cck 8, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck 8/product/TargetMol
    Average 96 stars, based on 1 article reviews
    cck 8 - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    99
    MedChemExpress cck 8 solution
    USP30-AS1 knockdown inhibits breast cancer cell proliferation both in vitro and in vivo . (A) The knockdown efficacy of USP30-AS1 siRNA and shRNA was validated by qRT-PCR analysis. (B) The effect of USP30-AS1 knockdown on MDA-MB-231 cell proliferation was evaluated <t>by</t> <t>CCK-8</t> assays. (C) The impact of USP30-AS1 knockdown on the proliferative capacity of MDA-MB-231 cells was assessed by colony formation assays. (D) Flow cytometry analysis was performed to determine the effect of USP30-AS1 knockdown on the cell cycle progression of MDA-MB-231 cells. (E) EdU assays were conducted in MDA-MB-231 cells with USP30-AS1 knockdown. (F) A xenograft tumor experiment was conducted using three MDA-MB-231 cell lines: shNC, shUSP30-AS1#1, and shUSP30-AS1#2. (G) Tumor growth and tumor weight were assessed every two days. (H) The actual photo of tumors for each group was collected at the end of the experiment. (I) Hematoxylin and eosin staining of tumor tissues from nude mice. (J) Immunohistochemistry assays were performed to determine the impact of USP30-AS1 knockdown on Ki67 expression within xenograft tumor tissues.
    Cck 8 Solution, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck 8 solution/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    cck 8 solution - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress cck 8 kit
    Ferroptosis inducers cause cell death and affect PD-L1 expression, which can be inhibited by iron chelators. (A, B) A549 and H1299 cells were treated with erastin or RSL3 at different concentration gradients for 24 h, and cell viability was detected using <t>the</t> <t>CCK-8</t> kit. Subsequently, cells were co-treated with DFO (100 μM), ferrostatin-1 (2 μM), and the aforementioned ferroptosis inducers at different concentrations for another 24 h, with cell viability re-detected by CCK-8.(C) A549 and H1299 cells were treated with erastin (20 μM) and RSL3 (5 μM), respectively, for 0, 3, 6, 12, 18, and 24 h. PD-L1 expression was measured by qPCR.(D) After A549 and H1299 cells were treated with erastin (20 μM) for 24 h, they were further treated with DFO (100 μM) and ferrostatin-1 (2 μM) alone or in combination. PD-L1 expression in cells was then detected. (E) A549 and H1299 cells were treated with erastin (20 μM) for 24 h, and intracellular ROS was detected by flow cytometry. CCK-8, cell counting kit-8; DFO, deferoxamine; qPCR, quantitative polymerase chain reaction; PD-L1, programmed death-ligand 1; ROS, reactive oxygen species. *** p < 0.001.
    Cck 8 Kit, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck 8 kit/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    cck 8 kit - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co cell counting kit 8 cck 8 assay
    Bta-miR-30f promoted proliferation and differentiation of buffalo intramuscular preadipocytes (A) Overexpression efficiency of bta-miR-30f mimics after 24 h ( n = 4 biologically independent experiments). (B–D) qRT-PCR was used to detect the adipogenesis genes PPARG , C/EBPα , FABP4 , (C) fatty acid uptake and triglyceride synthesis genes FAT/CD36 , GPAM , LIPN , XDH , and (D) Fatty acid desaturation and elongation genes SCD , FADS1 , FADS2 , and ELOVL5 ( n = 4 biologically independent experiments). (E) After transfection with MNC or bta-miR-30f mimics for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with MNC or bta-miR-30f mimics for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) The EdU assay was performed in intramuscular preadipocytes at 24 h after transfection with MNC or bta-miR-30f mimics. Cells were stained with EdU (red), and cell nuclei were stained with Hoechst (blue) ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) The percentages of EdU-positive cells ( n = 10 biologically independent experiments). <t>(J)</t> <t>CCK-8</t> assays were performed to determine cell proliferation ( n = 10 biologically independent experiments). All data are presented as mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Cell Counting Kit 8 Cck 8 Assay, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell counting kit 8 cck 8 assay/product/Vazyme Biotech Co
    Average 99 stars, based on 1 article reviews
    cell counting kit 8 cck 8 assay - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    MedChemExpress cell counting kit 8 cck 8 assay
    Bta-miR-30f promoted proliferation and differentiation of buffalo intramuscular preadipocytes (A) Overexpression efficiency of bta-miR-30f mimics after 24 h ( n = 4 biologically independent experiments). (B–D) qRT-PCR was used to detect the adipogenesis genes PPARG , C/EBPα , FABP4 , (C) fatty acid uptake and triglyceride synthesis genes FAT/CD36 , GPAM , LIPN , XDH , and (D) Fatty acid desaturation and elongation genes SCD , FADS1 , FADS2 , and ELOVL5 ( n = 4 biologically independent experiments). (E) After transfection with MNC or bta-miR-30f mimics for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with MNC or bta-miR-30f mimics for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) The EdU assay was performed in intramuscular preadipocytes at 24 h after transfection with MNC or bta-miR-30f mimics. Cells were stained with EdU (red), and cell nuclei were stained with Hoechst (blue) ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) The percentages of EdU-positive cells ( n = 10 biologically independent experiments). <t>(J)</t> <t>CCK-8</t> assays were performed to determine cell proliferation ( n = 10 biologically independent experiments). All data are presented as mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Cell Counting Kit 8 Cck 8 Assay, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell counting kit 8 cck 8 assay/product/MedChemExpress
    Average 99 stars, based on 1 article reviews
    cell counting kit 8 cck 8 assay - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    99
    Vazyme Biotech Co cck 8 working solution
    Bta-miR-30f promoted proliferation and differentiation of buffalo intramuscular preadipocytes (A) Overexpression efficiency of bta-miR-30f mimics after 24 h ( n = 4 biologically independent experiments). (B–D) qRT-PCR was used to detect the adipogenesis genes PPARG , C/EBPα , FABP4 , (C) fatty acid uptake and triglyceride synthesis genes FAT/CD36 , GPAM , LIPN , XDH , and (D) Fatty acid desaturation and elongation genes SCD , FADS1 , FADS2 , and ELOVL5 ( n = 4 biologically independent experiments). (E) After transfection with MNC or bta-miR-30f mimics for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with MNC or bta-miR-30f mimics for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) The EdU assay was performed in intramuscular preadipocytes at 24 h after transfection with MNC or bta-miR-30f mimics. Cells were stained with EdU (red), and cell nuclei were stained with Hoechst (blue) ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) The percentages of EdU-positive cells ( n = 10 biologically independent experiments). <t>(J)</t> <t>CCK-8</t> assays were performed to determine cell proliferation ( n = 10 biologically independent experiments). All data are presented as mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Cck 8 Working Solution, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck 8 working solution/product/Vazyme Biotech Co
    Average 99 stars, based on 1 article reviews
    cck 8 working solution - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    USP30-AS1 knockdown inhibits breast cancer cell proliferation both in vitro and in vivo . (A) The knockdown efficacy of USP30-AS1 siRNA and shRNA was validated by qRT-PCR analysis. (B) The effect of USP30-AS1 knockdown on MDA-MB-231 cell proliferation was evaluated by CCK-8 assays. (C) The impact of USP30-AS1 knockdown on the proliferative capacity of MDA-MB-231 cells was assessed by colony formation assays. (D) Flow cytometry analysis was performed to determine the effect of USP30-AS1 knockdown on the cell cycle progression of MDA-MB-231 cells. (E) EdU assays were conducted in MDA-MB-231 cells with USP30-AS1 knockdown. (F) A xenograft tumor experiment was conducted using three MDA-MB-231 cell lines: shNC, shUSP30-AS1#1, and shUSP30-AS1#2. (G) Tumor growth and tumor weight were assessed every two days. (H) The actual photo of tumors for each group was collected at the end of the experiment. (I) Hematoxylin and eosin staining of tumor tissues from nude mice. (J) Immunohistochemistry assays were performed to determine the impact of USP30-AS1 knockdown on Ki67 expression within xenograft tumor tissues.

    Journal: Genes & Diseases

    Article Title: Nuclear and cytoplasmic USP30-AS1 coordinately regulate breast cancer progression through HnRNPF/p21 and EZH2/c-Myc/p21 axes

    doi: 10.1016/j.gendis.2025.101684

    Figure Lengend Snippet: USP30-AS1 knockdown inhibits breast cancer cell proliferation both in vitro and in vivo . (A) The knockdown efficacy of USP30-AS1 siRNA and shRNA was validated by qRT-PCR analysis. (B) The effect of USP30-AS1 knockdown on MDA-MB-231 cell proliferation was evaluated by CCK-8 assays. (C) The impact of USP30-AS1 knockdown on the proliferative capacity of MDA-MB-231 cells was assessed by colony formation assays. (D) Flow cytometry analysis was performed to determine the effect of USP30-AS1 knockdown on the cell cycle progression of MDA-MB-231 cells. (E) EdU assays were conducted in MDA-MB-231 cells with USP30-AS1 knockdown. (F) A xenograft tumor experiment was conducted using three MDA-MB-231 cell lines: shNC, shUSP30-AS1#1, and shUSP30-AS1#2. (G) Tumor growth and tumor weight were assessed every two days. (H) The actual photo of tumors for each group was collected at the end of the experiment. (I) Hematoxylin and eosin staining of tumor tissues from nude mice. (J) Immunohistochemistry assays were performed to determine the impact of USP30-AS1 knockdown on Ki67 expression within xenograft tumor tissues.

    Article Snippet: The cells were seeded into a 96-well plate (2 × 10 3 /well) and cultured for 0, 24, 48, 72, and 96 h. Cells were treated with 10% CCK-8 solution (MedChemExpress, # HY-K0301) and incubated for 2 h. OD 450 was determined using a microplate reader.

    Techniques: Knockdown, In Vitro, In Vivo, shRNA, Quantitative RT-PCR, CCK-8 Assay, Flow Cytometry, Staining, Immunohistochemistry, Expressing

    Ferroptosis inducers cause cell death and affect PD-L1 expression, which can be inhibited by iron chelators. (A, B) A549 and H1299 cells were treated with erastin or RSL3 at different concentration gradients for 24 h, and cell viability was detected using the CCK-8 kit. Subsequently, cells were co-treated with DFO (100 μM), ferrostatin-1 (2 μM), and the aforementioned ferroptosis inducers at different concentrations for another 24 h, with cell viability re-detected by CCK-8.(C) A549 and H1299 cells were treated with erastin (20 μM) and RSL3 (5 μM), respectively, for 0, 3, 6, 12, 18, and 24 h. PD-L1 expression was measured by qPCR.(D) After A549 and H1299 cells were treated with erastin (20 μM) for 24 h, they were further treated with DFO (100 μM) and ferrostatin-1 (2 μM) alone or in combination. PD-L1 expression in cells was then detected. (E) A549 and H1299 cells were treated with erastin (20 μM) for 24 h, and intracellular ROS was detected by flow cytometry. CCK-8, cell counting kit-8; DFO, deferoxamine; qPCR, quantitative polymerase chain reaction; PD-L1, programmed death-ligand 1; ROS, reactive oxygen species. *** p < 0.001.

    Journal: Translational Oncology

    Article Title: Ferroptosis induction enhances anti-PD-1 efficacy in NSCLC via HIF-1α/PD-L1 modulation

    doi: 10.1016/j.tranon.2026.102685

    Figure Lengend Snippet: Ferroptosis inducers cause cell death and affect PD-L1 expression, which can be inhibited by iron chelators. (A, B) A549 and H1299 cells were treated with erastin or RSL3 at different concentration gradients for 24 h, and cell viability was detected using the CCK-8 kit. Subsequently, cells were co-treated with DFO (100 μM), ferrostatin-1 (2 μM), and the aforementioned ferroptosis inducers at different concentrations for another 24 h, with cell viability re-detected by CCK-8.(C) A549 and H1299 cells were treated with erastin (20 μM) and RSL3 (5 μM), respectively, for 0, 3, 6, 12, 18, and 24 h. PD-L1 expression was measured by qPCR.(D) After A549 and H1299 cells were treated with erastin (20 μM) for 24 h, they were further treated with DFO (100 μM) and ferrostatin-1 (2 μM) alone or in combination. PD-L1 expression in cells was then detected. (E) A549 and H1299 cells were treated with erastin (20 μM) for 24 h, and intracellular ROS was detected by flow cytometry. CCK-8, cell counting kit-8; DFO, deferoxamine; qPCR, quantitative polymerase chain reaction; PD-L1, programmed death-ligand 1; ROS, reactive oxygen species. *** p < 0.001.

    Article Snippet: Reagents and Antibodies Cell culture media and reagents: Ham's F-12 K, DMEM, RPMI-1640 (Servicebio), BCA protein assay kit, CCK-8 kit, RIPA lysis buffer (Servicebio), Lovastatin, Fluvastatin, RSL3, Erastin (MCE), deferoxamine mesylate, and Ferrostatin-1 (MCE).

    Techniques: Expressing, Concentration Assay, CCK-8 Assay, Flow Cytometry, Cell Counting, Real-time Polymerase Chain Reaction

    Bta-miR-30f promoted proliferation and differentiation of buffalo intramuscular preadipocytes (A) Overexpression efficiency of bta-miR-30f mimics after 24 h ( n = 4 biologically independent experiments). (B–D) qRT-PCR was used to detect the adipogenesis genes PPARG , C/EBPα , FABP4 , (C) fatty acid uptake and triglyceride synthesis genes FAT/CD36 , GPAM , LIPN , XDH , and (D) Fatty acid desaturation and elongation genes SCD , FADS1 , FADS2 , and ELOVL5 ( n = 4 biologically independent experiments). (E) After transfection with MNC or bta-miR-30f mimics for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with MNC or bta-miR-30f mimics for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) The EdU assay was performed in intramuscular preadipocytes at 24 h after transfection with MNC or bta-miR-30f mimics. Cells were stained with EdU (red), and cell nuclei were stained with Hoechst (blue) ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) The percentages of EdU-positive cells ( n = 10 biologically independent experiments). (J) CCK-8 assays were performed to determine cell proliferation ( n = 10 biologically independent experiments). All data are presented as mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: iScience

    Article Title: Bta-miR-30f promotes adipogenesis and unsaturated fatty acid accumulation by targeting RAD23B in buffalo intramuscular preadipocytes

    doi: 10.1016/j.isci.2025.114578

    Figure Lengend Snippet: Bta-miR-30f promoted proliferation and differentiation of buffalo intramuscular preadipocytes (A) Overexpression efficiency of bta-miR-30f mimics after 24 h ( n = 4 biologically independent experiments). (B–D) qRT-PCR was used to detect the adipogenesis genes PPARG , C/EBPα , FABP4 , (C) fatty acid uptake and triglyceride synthesis genes FAT/CD36 , GPAM , LIPN , XDH , and (D) Fatty acid desaturation and elongation genes SCD , FADS1 , FADS2 , and ELOVL5 ( n = 4 biologically independent experiments). (E) After transfection with MNC or bta-miR-30f mimics for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with MNC or bta-miR-30f mimics for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) The EdU assay was performed in intramuscular preadipocytes at 24 h after transfection with MNC or bta-miR-30f mimics. Cells were stained with EdU (red), and cell nuclei were stained with Hoechst (blue) ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) The percentages of EdU-positive cells ( n = 10 biologically independent experiments). (J) CCK-8 assays were performed to determine cell proliferation ( n = 10 biologically independent experiments). All data are presented as mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: Cell Counting Kit-8 (CCK-8) assay , Vazyme , cat#A311.

    Techniques: Over Expression, Quantitative RT-PCR, Transfection, Staining, Quantitation Assay, Spectrophotometry, EdU Assay, CCK-8 Assay

    Bta-miR-30f inhibitor suppressed the proliferation and differentiation of buffalo intramuscular preadipocytes (A) qRT-PCR analysis of bta-miR-30f transcript levels ( n = 4 biologically independent experiments). (B–D) bta-miR-30f knockdown reduced the mRNA levels of genes related to adipogenic ( PPARG , C/EBPα , FABP4 ), (C) triglyceride (TG) synthesis (FAT/ CD36 , LIPN , and XDH ), and (D) fatty acid desaturation and elongation ( SCD , FADS1 , FADS2 , ELOVL5 ) ( n = 4 biologically independent experiments), respectively. (E) After transfection with INC or Inhibitor for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with INC or Inhibitor for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) After transfection with the bta-miR-30f inhibitor or INC for 24 h, the EdU staining assay was performed ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) Quantification ratio of EdU cells/total cells ( n = 10 biologically independent experiments). (J) CCK-8 analysis ( n = 10 biologically independent experiments). All data are presented as the mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using the unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: iScience

    Article Title: Bta-miR-30f promotes adipogenesis and unsaturated fatty acid accumulation by targeting RAD23B in buffalo intramuscular preadipocytes

    doi: 10.1016/j.isci.2025.114578

    Figure Lengend Snippet: Bta-miR-30f inhibitor suppressed the proliferation and differentiation of buffalo intramuscular preadipocytes (A) qRT-PCR analysis of bta-miR-30f transcript levels ( n = 4 biologically independent experiments). (B–D) bta-miR-30f knockdown reduced the mRNA levels of genes related to adipogenic ( PPARG , C/EBPα , FABP4 ), (C) triglyceride (TG) synthesis (FAT/ CD36 , LIPN , and XDH ), and (D) fatty acid desaturation and elongation ( SCD , FADS1 , FADS2 , ELOVL5 ) ( n = 4 biologically independent experiments), respectively. (E) After transfection with INC or Inhibitor for 24 h, lipid accumulation was assessed by Oil Red O staining following an 8-day induction period ( n = 3 biologically independent experiments). Scale bars, 200 μm. (F) Histogram shows the quantitation of Oil Red O staining by spectrophotometry at 510 nm ( n = 3 biologically independent experiments). (G) After transfection with INC or Inhibitor for 24 h, triglyceride levels were measured following an 8-day induction period ( n = 4 biologically independent experiments). (H) After transfection with the bta-miR-30f inhibitor or INC for 24 h, the EdU staining assay was performed ( n = 10 biologically independent experiments). Scale bars, 200 μm. (I) Quantification ratio of EdU cells/total cells ( n = 10 biologically independent experiments). (J) CCK-8 analysis ( n = 10 biologically independent experiments). All data are presented as the mean ± SE. (A, B, C, D, F, G, I, and J) Statistical analyses using the unpaired t test were performed on GraphPad Prism 8.0, where ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: Cell Counting Kit-8 (CCK-8) assay , Vazyme , cat#A311.

    Techniques: Quantitative RT-PCR, Knockdown, Transfection, Staining, Quantitation Assay, Spectrophotometry, CCK-8 Assay